Company News in the Life Science Industry

»

Reset 

ALIGN TECHNOLOGY FOUNDATION COMMITS US$ 1 MILLION DONATION FOR COVID-19 RELIEF EFFORTS

Read more ››
By: GlobenewsWire - 26 Mar 2020
Related companies:  Align Technology, Inc.

RECORDATI SUBMITS NEW DRUG APPLICATION FOR ISTURISA® IN JAPAN

Read more ››
By: GlobenewsWire - 26 Mar 2020

Arvelle Announces European Medicines Agency Acceptance of the Marketing Authorization Application for Cenobamate

Read more ››
By: GlobenewsWire - 26 Mar 2020
Related companies:  Arvelle Therapeutics

Beroni Group Announces Submission of Emergency Use Authorization to US FDA for its COVID-19 Rapid Test Detection Kit

Read more ››
By: GlobenewsWire - 26 Mar 2020

Passing of Genmab A/S’ Annual General Meeting

Read more ››
By: GlobenewsWire - 26 Mar 2020
Related companies:  Genmab A/S

Resolutions from the Annual General Meeting of Novo Nordisk A/S

Read more ››
By: GlobenewsWire - 26 Mar 2020

Monthly information regarding the total number of voting rights and total number of shares of the Company

Read more ››
By: GlobenewsWire - 26 Mar 2020
Related companies:  DBV Technologies S.A.

Alcohol Industry Veteran Mark Gorman Appointed Executive Vice President and Chief Operating Officer of the National Association of Cannabis Businesses

Read more ››
By: GlobenewsWire - 26 Mar 2020

athenahealth Leaders Honored by the Healthcare Businesswomen's Association for Transformational Leadership & Commitment to Excellence

Read more ››
By: GlobenewsWire - 26 Mar 2020
Related companies:  athenahealth, Inc.

Novo Nordisk A/S - Articles of Association

Read more ››
By: GlobenewsWire - 26 Mar 2020

Baudax Bio Announces Closing of $25 Million Public Offering of Securities

Read more ››
By: GlobenewsWire - 26 Mar 2020
Related companies:  Baudax Bio, Inc.

Anticoagulation protocol reduces venous thromboembolisms in patients with traumatic brain injury

Read more ››
By: GlobenewsWire - 26 Mar 2020

Resolutions passed at the Annual General Meeting

Read more ››
By: GlobenewsWire - 26 Mar 2020
Related companies:  Orphazyme A/S

Nexstim Plc completes negotiations under the co-operation within undertakings act

Read more ››
By: GlobenewsWire - 26 Mar 2020

OSE Immunotherapeutics Reports 2019 Financial Results and Provides Business Update Expectations for Potential Impact of COVID-19 on the Company’s Clinical Development Activities

Read more ››
By: GlobenewsWire - 26 Mar 2020
Related companies:  OSE Immunotherapeutics

Tabula Rasa HealthCare® Names Frank Sparacino SVP Investor Relations and Corporate Development

Read more ››
By: GlobenewsWire - 26 Mar 2020
Related companies:  Tabula Rasa HealthCare

Innocoll Holdings Limited Announces FDA Acceptance of New Drug Application for XARACOLL® for the Management of Postsurgical Pain after Open Inguinal Hernia Surgery

ATHLONE, Ireland, March 26, 2020 /PRNewswire/ -- Innocoll Holdings Limited, a specialty pharmaceutical company and portfolio business of Gurnet Point Capital, today announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) resubmission for XARACOLL®... Read more ››

By: PR Newswire Association LLC. - 26 Mar 2020
Related companies:  Innocoll Holdings plc

Orexo Publishes the Annual Report for 2019

UPPSALA, Sweden, March 26, 2020 /PRNewswire/ -- Annual Report, including the Sustainability Report, for the 2019 fiscal year has been published. The Annual Report can be downloaded on the company's website, Read more ››

By: PR Newswire Association LLC. - 26 Mar 2020
Related companies:  Orexo AB

Biotage Postpones the AGM Until June 4, 2020

UPPSALA, Sweden, March 26, 2020 /PRNewswire/ -- The developing spread of the outbreak of the coronavirus COVID-19 is causing great difficulties to access with accuracy the economic situation for the society as such but also for Biotage and its customers. Authorities around the globe have introduced... Read more ››

By: PR Newswire Association LLC. - 26 Mar 2020
Related companies:  Biotage AB

Evox Therapeutics and Takeda Sign Multi-target Rare Disease Collaboration

OXFORD, England, March 26, 2020 /PRNewswire/ -- Evox Therapeutics Ltd ('Evox' or the 'Company'), a leading exosome therapeutics company, is pleased to announce the signing of a rare disease-focused partnership with Takeda Pharmaceutical Company Limited ("Takeda"). The multi-target collaboration... Read more ››

By: PR Newswire Association LLC. - 26 Mar 2020
Related companies:  Evox Therapeutics Limited
«  1  2  3  4  5  6  7  8 9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Explore our database of over 50,000 companies